U.S. Infusion Therapy Device Market to Exceed $3.6 Billion by 2029, Fueled by High Demand in Outpatient Care
The U.S. Infusion Therapy Device Market is on an upward trajectory. By 2029, the market is predicted to exceed $3.6 billion.
VANCOUVER, BRITISH COLUMBIA, CANADA, May 10, 2023/EINPresswire.com/ -- iData Research, a globally recognized consulting and market research firm, has recently released an exclusive report on the Infusion Therapy Device Market in the United States. The research provides valuable insights into market trends, developments, and competition. According to the report, as healthcare costs continue to rise, the infusion therapy device market is seeing a surge in growth in outpatient settings. Patients are opting for treatment in non-hospital settings like homecare, ambulatory surgical centers, and specialty clinics. This trend has caused a spike in the cost per device, as alternate care sites have less purchasing power compared to group purchasing organizations. As a result, Infusion therapy products are becoming more expensive, but the demand for these premium products remains high, driving the growth of the infusion therapy device market.
The U.S. Infusion Therapy Device Market is on an upward trajectory. By 2029, the market is predicted to exceed $3.6 billion. This comprehensive report delves into industry dynamics, unit sales, ASPs, market drivers and limiters, market share statistics, key industry competitors, and more, providing a complete analysis of all the segments of the market.
The report’s segmentation includes detailed analysis of several markets including: infusion pumps, infusion sets (IV sets), needleless connectors, stopcocks for infusion systems, intravenous filters and devices designed for blood transfusion.
Becton Dickinson led the U.S. infusion therapy device and consumables market in 2022, with a strong presence in nearly every major market segment and leading in infusion pumps, IV sets, and needleless connectors. ICU Medical was the second-largest competitor, holding major market shares in infusion pump, IV set, and needleless connector markets and acquiring Smiths Medical in 2022. Baxter ranked third, offering a comprehensive range of products in multiple market segments and maintaining its position as a strong player in the market by offering a broad portfolio of high-quality products and leveraging its extensive distribution network.
Key Questions Answered in this Report:
How has the U.S. Infusion Therapy Device Market performed so far and how will it perform in the coming years?
What are the key regional markets?
What are the key driving factors and challenges in the industry?
What is the structure of the U.S. Infusion Therapy Device Market and what are the market shares of the key players?
What is the degree of competition in the industry?
For extended insights, be sure to read our full 2023 U.S. Infusion Therapy Device Market report.
For further Information, more insights like this can be found in the latest reports by iData. Please email us at marketing@idataresearch.net or register online for a brochure and synopsis.
About iData
iData Research is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, and pharmaceutical industries.
Dejan Popic
iData Research
+1 604-266-6933
email us here
Visit us on social media:
Facebook
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
